ArticleAntimicrobial agents and chemotherapy2017

Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor.

Paul G Ambrose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.